A M Boerbooms

COMPARISON OF METHOTREXATE WITH PLACEBO IN THE TREATMENT OF SYSTEMIC SCLEROSIS: A 24 WEEK RANDOMIZED DOUBLE-BLIND TRIAL, FOLLOWED BY A 24 WEEK OBSERVATIONAL TRIAL

F.H.J. van den Hoogen, A M Boerbooms, A. J. G. Swaak et al. · Lara D. Veeken · 1996 · 359 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Circulating soluble tumor necrosis factor receptors, interleukin‐2 receptors, tumor necrosis factor α, and interleukin‐6 levels in rheumatoid arthritis.

Pilar Barrera, A M Boerbooms, Elly M. Janssen et al. · Arthritis & Rheumatism · 1993 · 139 citations

Life Sciences, Immunology, Pharmacology +13

Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis

Jan Stolk, A M Boerbooms, Ronney A. De Abreu et al. · Arthritis & Rheumatism · 1998 · 116 citations · Full text

Medicine, Internal Medicine, Pharmacology +16

Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty‐eight–week randomized, double‐blind trial

M. E. C. Jeurissen, A M Boerbooms, Levinus B. A. van de Putte et al. · Arthritis & Rheumatism · 1991 · 116 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

R Hoet, A M Boerbooms, Maarten Arends et al. · Annals of the Rheumatic Diseases · 1991 · 96 citations

Life Sciences, Immunology, Pathobiology +16